Somatostatin analogs as adjuncts to agonists of luteinizing hormone-releasing hormone in the treatment of experimental prostate cancer.

Documenti analoghi

• Receptors for prolactin, somatostatin, and luteinizing hormone-releasing hormone in experimental prostate cancer after treatment with analogs of luteinizing hormone-releasing hormone and somatostatin.
  di: Kadar, T, et al.
  Pubblicazione: (1988)
• Treatment of nitrosamine-induced pancreatic tumors in hamsters with analogs of somatostatin and luteinizing hormone-releasing hormone.
  di: Paz-Bouza, J I, et al.
  Pubblicazione: (1987)
• Inhibition of mammary tumor growth in rats and mice by administration of agonistic and antagonistic analogs of luteinizing hormone-releasing hormone.
  di: Redding, T W, et al.
  Pubblicazione: (1983)
• Programmed cell death (apoptosis) in pancreatic cancers of hamsters after treatment with analogs of both luteinizing hormone-releasing hormone and somatostatin.
  di: Szende, B, et al.
  Pubblicazione: (1989)
• Combination of long-acting microcapsules of the D-tryptophan-6 analog of luteinizing hormone-releasing hormone with chemotherapy: investigation in the rat prostate cancer model.
  di: Schally, A V, et al.
  Pubblicazione: (1985)